116 related articles for article (PubMed ID: 11344045)
1. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro.
Benford HL; McGowan NW; Helfrich MH; Nuttall ME; Rogers MJ
Bone; 2001 May; 28(5):465-73. PubMed ID: 11344045
[TBL] [Abstract][Full Text] [Related]
2. RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.
Sutherland KA; Rogers HL; Tosh D; Rogers MJ
Arthritis Res Ther; 2009; 11(2):R58. PubMed ID: 19405951
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.
Ebetino FH; Sun S; Cherian P; Roshandel S; Neighbors JD; Hu E; Dunford JE; Sedghizadeh PP; McKenna CE; Srinivasan V; Boeckman RK; Russell RGG
Bone; 2022 Mar; 156():116289. PubMed ID: 34896359
[TBL] [Abstract][Full Text] [Related]
4.
Surface LE; Burrow DT; Li J; Park J; Kumar S; Lyu C; Song N; Yu Z; Rajagopal A; Bae Y; Lee BH; Mumm S; Gu CC; Baker JC; Mohseni M; Sum M; Huskey M; Duan S; Bijanki VN; Civitelli R; Gardner MJ; McAndrew CM; Ricci WM; Gurnett CA; Diemer K; Wan F; Costantino CL; Shannon KM; Raje N; Dodson TB; Haber DA; Carette JE; Varadarajan M; Brummelkamp TR; Birsoy K; Sabatini DM; Haller G; Peterson TR
Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434850
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profile of bisphosphonates in the treatment of metabolic bone disorders.
Sinigaglia L; Varenna M; Casari S
Clin Cases Miner Bone Metab; 2007 Jan; 4(1):30-6. PubMed ID: 22460750
[TBL] [Abstract][Full Text] [Related]
6. Regulation of apoptosis in osteoclasts and osteoblastic cells.
Xing L; Boyce BF
Biochem Biophys Res Commun; 2005 Mar; 328(3):709-20. PubMed ID: 15694405
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF
J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of caspase-8 cascade restrains the osteoclastogenic fate of bone marrow cells.
Veselá B; Ševčíková A; Holomková K; Ramešová A; Kratochvílova A; Sharpe PT; Matalová E
Pflugers Arch; 2024 Jun; ():. PubMed ID: 38833170
[TBL] [Abstract][Full Text] [Related]
9. The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages.
Henning P; Westerlund A; Movérare-Skrtic S; Lindholm C; Márquez-Méndez M; Nilsson S; Holmberg AR; Lerner UH
Invest New Drugs; 2024 Apr; 42(2):207-220. PubMed ID: 38427117
[TBL] [Abstract][Full Text] [Related]
10.
Li S; Han X; Liu N; Chang J; Liu G; Hu S
Front Immunol; 2023; 14():1285442. PubMed ID: 38264658
[TBL] [Abstract][Full Text] [Related]
11. An Evaluation of the Effectiveness of Local Delivery of Zoledronic Acid in Accelerating Bone Healing After the Extraction of Mandibular Third Molars.
Ahmed B; Alkhouri I; Albassal A; Shehada A
Cureus; 2023 Feb; 15(2):e35503. PubMed ID: 37007343
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer bone metastases biology and clinical management (Review).
Archer Goode E; Wang N; Munkley J
Oncol Lett; 2023 Apr; 25(4):163. PubMed ID: 36960185
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target.
Muehlebach ME; Holstein SA
Clin Transl Med; 2023 Jan; 13(1):e1167. PubMed ID: 36650113
[TBL] [Abstract][Full Text] [Related]
14. Osteogenesis Improvement of Gelatin-Based Nanocomposite Scaffold by Loading Zoledronic Acid.
Abdulahy SB; Esmaeili Bidhendi M; Vaezi MR; Moosazadeh Moghaddam M
Front Bioeng Biotechnol; 2022; 10():890583. PubMed ID: 35547164
[TBL] [Abstract][Full Text] [Related]
15. A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.
Bullock G; Miller CA; McKechnie A; Hearnden V
Front Oral Health; 2021; 2():822411. PubMed ID: 35224540
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid modulates osteoclast apoptosis through activation of the NF-κB signaling pathway in ovariectomized rats.
Cheng YT; Liao J; Zhou Q; Huo H; Zellmer L; Tang ZL; Ma H; Hong W; Liao DJ
Exp Biol Med (Maywood); 2021 Aug; 246(15):1727-1739. PubMed ID: 33926259
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals.
Møller AMJ; Delaisse JM; Olesen JB; Bechmann T; Madsen JS; Søe K
JBMR Plus; 2020 Nov; 4(11):e10412. PubMed ID: 33210064
[TBL] [Abstract][Full Text] [Related]
18. The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases.
Kolb AD; Bussard KM
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330786
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways.
Huang XL; Huang LY; Cheng YT; Li F; Zhou Q; Wu C; Shi QH; Guan ZZ; Liao J; Hong W
Int J Mol Med; 2019 Aug; 44(2):582-592. PubMed ID: 31173157
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
